Hula Therapeutics

Private

Philadelphia, PennsylvaniaHealthcare & Life Scienceshttps://hulatx.com/

Last Round

Seed

Jul 19, 2024

Total Funding Raised

$250,000

Company Overview

Hula Therapeutics is a biotechnology company that develops precision immunotherapies for the treatment of solid tumors in children and adults.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Precision Medicine, Clinical Trials, Drug Discovery

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Keywords

CAR-T cell therapyprecision immunotherapysolid tumor treatmentcell therapycancer immunotherapyimmunopeptidomicsprotein engineeringpeptide-centric therapyneuroblastoma treatmentHLA-targeted therapynext-gen CAR-Tpediatric oncologybiotech startup

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Hula Therapeutics Comparables

Compare Hula Therapeutics with similar companies based on industry and business-model similarity.

Hula Therapeutics comparables — related companies by embedding similarity
Company	Similarity	Market Cap
Affini-T Therapeutics	85%
Myrio Therapeutics	83%
A2 Biotherapeutics	76%

View all Comparables

Hula Therapeutics Funding Rounds

Historical fundraising activity

Data table
Round	Date	Amount Raised	Valuation	Investors	Sources
Seed	Jul 19, 2024

View all Funding Rounds

Key People

Founding team and executive leadership

Steven Gelone

Founder, President & CEO

Founding Team

Hula Therapeutics Investors

Notable investors and investment history

Hula Therapeutics investors
Investor	Rounds
BioAdvance Capital	Seed
Hatch Biofund	Seed

View all Investors

Hula Therapeutics Filings

SEC and related filings with document metadata.

Data table
Typed	Date	Amount Offered	Amount Sold	Filling	Pages	Download
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation

Hula Therapeutics Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Hula Therapeutics's valuation, stock price, and market status.

Firmographic Details

HeadquartersPhiladelphia, Pennsylvania

Employee Range7

Year Founded2022

Last FundingJul 19, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.